切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (03) : 289 -295. doi: 10.3877/cma.j.issn.1674-6902.2019.03.005

所属专题: 文献

论著

肺纤维化合并肺气肿综合征并发肺动脉高压的Meta分析
石涵宇1, 董彦2,(), 魏路清3, 殷大伟3, 宗庆芸4   
  1. 1. 300162 天津,中国人民武装警察部队特色医学中心呼吸与重症医学科;300309 天津,武警后勤学院
    2. 300162 天津,中国人民武装警察部队特色医学中心超声心动图室
    3. 300162 天津,中国人民武装警察部队特色医学中心呼吸与重症医学科
    4. 300162 天津,天津下瓦房医院;300309 天津,武警后勤学院
  • 收稿日期:2018-07-10 出版日期:2019-06-20
  • 通信作者: 董彦
  • 基金资助:
    天津市自然科学基金资助项目(15JCZDJC35000)

Systematic review and meta-analysis on pulmonary hypertension in patients with combined fibrosis and emphysema syndrome

Hanyu Shi1, Yan Dong2,(), Luqing Wei3, Dawei Yin3, Qingyun Zong4   

  1. 1. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China; Armed Police Logistics College, Tianjin 300309, China
    2. Department of Ultrasound, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China
    3. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China
    4. Hospital of Xiawafang, Tianjin 300162, China; Armed Police Logistics College, Tianjin 300309, China
  • Received:2018-07-10 Published:2019-06-20
  • Corresponding author: Yan Dong
  • About author:
    Corresponding author: Dong Yan, Email:
引用本文:

石涵宇, 董彦, 魏路清, 殷大伟, 宗庆芸. 肺纤维化合并肺气肿综合征并发肺动脉高压的Meta分析[J]. 中华肺部疾病杂志(电子版), 2019, 12(03): 289-295.

Hanyu Shi, Yan Dong, Luqing Wei, Dawei Yin, Qingyun Zong. Systematic review and meta-analysis on pulmonary hypertension in patients with combined fibrosis and emphysema syndrome[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(03): 289-295.

目的

系统评价肺纤维化合并肺气肿(CPFE)综合征与特发性肺纤维化(IPF)或肺气肿/COPD相比肺动脉高压的发生率及肺动脉压力水平。

方法

计算机检索CBM、CNKI(中国知网)、Wan Fang Data(万方数据库)、VIP(维普)、PubMed、Embase及Cochrane Library,查找报道肺纤维化合并肺气肿综合征的全部文献,检索时间为2005年至2018年1月。由两位评价员按照纳入排除标准分别筛选文献,提取数据、评估文献,采用Revman5.3及Stata14.0软件进行分析。

结果

纳入13篇文献,共1 385例患者。Meta结果分析表明:CPFE综合征与独立存在的IPF相比,无论是肺动脉高压发生率[OR=1.93,95%CI(1.17,3.17),P=0.010]还是肺动脉压力水平[MD=11.89,95%CI(7.39,16.39),P<0.00001]都较高而且存在统计学差异。CPFE综合征与肺气肿/COPD相比,肺动脉高压的发生率[OR=2.62,95%CI(1.42,4.81),P=0.002]及肺动脉压力水平[MD=7.49,95%CI(5.27,9.72),P<0.00001]也较高且具有显著差异。

结论

CPFE综合征与IPF相比,肺动脉高压发生率及肺动脉压力水平均较高;CPFE综合征与肺气肿/COPD相比,肺动脉高压发生率及肺动脉压力水平也较高。CPFE综合征更容易并发肺动脉高压且更严重,对CPFE综合征患者应定期监测肺动脉压力从而实现早期诊断及治疗。

Objective

To evaluate systematically the incidence and the level of pulmonary hypertension in the patients with combined pulmonary fibrosis with emphysema (CPFE) syndrome compared with those of the patients with idiopathic pulmonary fibrosis (IPF) or pulmonary emphysema/chronic obstructive pulmonary disease (COPD).

Methods

All the reports about CPFE syndromes were collected by searching these databases including CBM, CNKI, Wan Fang Data, VIP, PubMed, Embase and the Cochrane library (12th in 2017) from January 2005 to January 2018. All the titles/abstracts were reviewed to identify the possible studies with predefined selection criteria. All the data were combined and analyzed using Review Manager 5.3 or Stata 14.0.

Results

A total of 1 385 patients included in 13 reports were selected for this meta-analysis. Compared with the IPF group, the CPFE group had a higher incidence [OR=1.93, 95%CI (1.17, 3.17), P=0.010] and a higher level [MD=11.89, 95%CI (7.39, 16.39), P<0.00001] of pulmonary hypertension. Meanwhile, the incidence [OR=2.62, 95%CI (1.42, 4.81), P=0.002] and the level [MD=7.49, 95%CI (5.27, 9.72), P<0.00001] of pulmonary hypertension also presented higher results compared with the pulmonary emphysema/COPD group.

Conclusion

CPFE syndrome manifests a higher incidence and a higher level of pulmonary hypertension when compared with the IPF group as well as the pulmonary emphysema/COPD group and should be monitored regularly.

图1 文献筛选流程及结果
表1 纳入研究的基本资料特征
表2 纳入文献偏倚风险评价表
图2 CPFE综合征与IPF肺动脉高压发生率比较的森林图
图3 CPFE综合征与IPF的肺动脉压力水平比较的森林图
图4 CPFE综合征与肺气肿/COPD肺动脉高压发生率比较的森林图
图5 CPFE综合征较肺气肿/COPD的肺动脉压力水平的森林图
1
单兆运,陈治安. 慢性阻塞性肺疾病的光镜,电镜及免疫病理研究[J]. 中华结核和呼吸杂志,1990, 13(5): 311-313.
2
Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment[J]. Respir Med, 1990, 84(5): 365-369.
3
Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity[J]. Eur Respir J, 2005, 26(4): 586-593.
4
Shlobin OA, Nathan SD. Pulmonary hypertension secondary to interstitial lung disease[J]. Expert Rev Respir Med, 2011, 5(2): 179-189.
5
D′Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry[J]. Ann Intern Med, 1991, 115(5): 343-349.
6
Mejía M, Carrillo G, Rojasserrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.[J]. Chest, 2009, 136(1): 10-15.
7
秦文婧,梁宇,齐红松. 肺间质纤维化合并肺气肿综合征的临床特点分析[J]. 中国当代医药,2016, 23(13): 26-28.
8
赵丽娜. 肺间质纤维化合并肺气肿综合征21例临床分析[D]. 延边大学,2016: 12-22.
9
Zhang L, Zhang C, Dong F, et al. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis[J]. Bmc Pulm Med, 2016, 16(1): 137.
10
Sato S, Tanino Y, Misa K, et al. Identification of Clinical Phenotypes in Idiopathic Interstitial Pneumonia with Pulmonary Emphysema[J]. Intern Med, 2015, 55(12): 1529-1535.
11
Jacob J, Bartholmai BJ, Rajagopalan S, et al. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema[J]. Respirology, 2018, 23(6): 593-599.
12
陈锋,张磊,唐家璇,等. 肺纤维化合并肺气肿与特发性肺纤维化的临床特征比较分析[J]. 医学理论与实践,2016, 29(10): 1263-1265.
13
Lee CH, Kim HJ, Park CM, et al. The impact of combined pulmonary fibrosis and emphysema on mortality[J]. Int J Tuberc Lung Dise, 2011, 15(8): 1111-1116.
14
Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
15
Johannessen A, Nilsen RM, Storeb M, et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization[J]. Am J Respir Crit Care Med, 2013, 188(1): 51-59.
16
Lau EM, Tamura Y, Mcgoon MD, et al. The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress[J]. Eur Respir J, 2015, 46(4): 879-882.
17
Mclaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association[J]. J Am Coll Cardiol, 2009 Apr 28; 53(17): 1573-619.
18
Wells GA, Shea BJ, O′Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis[J]. Applied Engineering in Agriculture, 2014, 18(6): 727-734.
19
Sugino K, Ishida F, Kikuchi N, et al. Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone[J]. Respirology, 2014, 19(2): 239-245.
20
Tomioka H, Mamesaya N, Yamashita S, et al. Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease[J]. BMJ Open Respir Res, 2016, 3(1): e000099.
21
陈恒屹,康军,崔社怀,等. 特发性肺间质纤维化合并肺气肿的临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(1): 7-11.
22
Ye Q, Huang KW, Ding Y, et al. Cigarette smoking contribute to idiopathic fibrosis associated with emphysema[J]. 中华医学杂志(英文版), 2014, 127(3): 469-474.
23
谭晓明. 肺间质纤维化合并肺气肿综合征的临床特点研究[D]. 北京,北京协和医学院,2013: 32-65.
24
Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome[J]. Eur Respir J, 2010, 35(1): 105-111.
25
Munson JC. Combined pulmonary fibrosis and emphysema: a high-pressure situation[J]. Eur Respir J, 2010, 35(1): 9-11.
26
Vargas CI, Buendiaroldan I, Avla MM, et al. Patients with Combined Pulmonary Fibrosis and Emphysema Show a Worse Heart Rate Recovery After Exercise Compared with Patients with Idiopathic Pulmonary Fibrosis[J]. Am J Respir Crit Care Med, 2015, 191: A1565.
27
Kawamukai M, Koyama M, Nishida J, et al. Prognostic evaluation of patients with pulmonary hypertension by combined non-invasive assessment of pulmonary vascular resistance and right ventricular function[J]. Eur Heart J, 2013, 34(suppl 1): 326.
28
Swift AJ, Rajaram S, Capener D, et al. S120 Right Ventricular Dysfunction In Pulmonary Hypertension With Combined Pulmonary Fibrosis And Emphysema Syndrome[J].Thorax, 69(suppl 2): A64-A65.
29
Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions[M]. John Wiley &Sons, 2011: 38-56.
30
Cottin V, Nunes H, Bérézné A, et al. Combined Pulmonary Emphysema And Fibrosis In Connective Tissue Disease[J]. Arthritis Rheum, 2011 Jan; 63(1): 295-304.
Cottin V. Combined pulmonary fibrosis and emphysema: bad and ugly all the same?[J]. Eur Respir J, 2017, 50(1): 1700846.
32
Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema[J]. Lung, 2010, 188(5): 365-373.
33
张天嵩,钟文昭,徐同成. 漏斗图的绘制与不对称检验在Stata中的实现[J]. 循证医学,2009, 9(2): 110-114.
[1] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[2] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[3] 程鹏, 杨道鸿, 邓文君, 钟宇琼, 胡晓雪, 黄小银, 周道扬. 纤维蛋白原治疗创伤性凝血病有效性和安全性的Meta分析[J]. 中华危重症医学杂志(电子版), 2024, 17(03): 225-231.
[4] 沈皓, 张驰, 韩旻轩, 陆晓庆, 周愉, 周莉丽. 骨皮质切开术对正畸治疗牙根吸收影响的Meta分析[J]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 175-184.
[5] 郭仁凯, 武慧铭, 李辉宇. 机器人辅助全系膜切除术治疗右半结肠癌有效性和安全性的Meta分析及试验序贯分析[J]. 中华普通外科学文献(电子版), 2024, 18(03): 234-240.
[6] 朱俊佳, 孙琦, 徐文龙, 陆天宇, 冯强, 储涛, 邢春根, 高春冬, 俞一峰, 赵振国. 永久性结肠造口预防性补片置入对预防造口旁疝价值的Meta分析[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 336-342.
[7] 王招荐, 曹桢, 郭小双, 靳小雷, 刘子文. 加速康复外科理念应用于腹壁重建手术的系统评价及Meta分析[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 343-350.
[8] 罗霞, 王宝梅, 李淑景, 杨英. 特发性肺动脉高压血清PCSK9表达及预后意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 585-589.
[9] 朱佑君, 付万垒, 毛杨, 李德峰. 细胞外基质相关标志物与成纤维细胞在肺动脉高压发展中的意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 356-362.
[10] 周璇, 谢莉, 邹娟. 尼达尼布对特发性肺纤维化肺功能、肺纤维化程度及PDGF、PGE2、TGF-β1的影响[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 368-372.
[11] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[12] 郁凯, 曾保起, 杨剑, 杨杰, 张殿英, 孙凤. 全关节镜与切开手术治疗肩袖撕裂疗效比较的系统综述与Meta分析[J]. 中华肩肘外科电子杂志, 2024, 12(03): 238-245.
[13] 田学, 谢晖, 王瑞兰. 急性呼吸窘迫综合征相关肺纤维化的研究进展[J]. 中华重症医学电子杂志, 2024, 10(03): 258-264.
[14] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[15] 吴欣, 袁晓晨, 沈慧, 秦建华. 三尖瓣反流速度评估肺动脉高压患者心脏结构改变的研究[J]. 中华临床医师杂志(电子版), 2024, 18(03): 259-267.
阅读次数
全文


摘要